Effects of food and esomeprazole on pharmacokinetics of sevabertinib
Ahmed Elsayed, Barbara J. Brennan, Michaela Damaske, Frank-Thorsten Hafner et autres
0 citations
NCODA Oncology and Hematology Meeting Abstracts
Barbara J. Brennan
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
90Publications signalées
821Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Cancer therapeutics and mechanismsNeuroblastoma Research and TreatmentsHepatitis C virus researchChildhood Cancer Survivors' Quality of LifeLung Cancer Treatments and Mutations
Les publications récentes
Clinical drug–drug interaction studies investigating pharmacokinetics and safety of sevabertinib
Barbara J. Brennan, Alissa Uddin, Michaela Damaske, Frank-Thorsten Hafner et autres
0 citations
NCODA Oncology and Hematology Meeting Abstracts
205P Nirogacestat pediatric compassionate use program: Cross-sectional data review
Barbara J. Brennan, Kelly Vallance, A.B. Oton, S. Scott et autres
gb, us (code pays fourni par la source)
0 citations
ESMO rare cancers.
Supplementary Figure S1 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Figure S3 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Data S2 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Table S3 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Table S2 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Table S1 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Figure S4 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Table S4 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
Supplementary Table S5 from Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, Guy Makin et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.